Sector Chart Noxopharm Limited

Equities

Delayed Australian S.E. Other stock markets 12:13:16 2024-05-17 am EDT			5-day change	1st Jan Change
0.079 ^AUD	+1.28%		+25.40%	+11.27%

Apr. 04	Noxopharm Receives AU$100,000 to Progress Brain Cancer Drug	MT
Feb. 27	Noxopharm Narrows Fiscal H1 Net Loss Despite Lower R&D Tax Incentive	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes